LMGAM
WX

Liberty Mutual Group Asset Management’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History

Liberty Mutual Group Asset Management’s Portfolio WX Stock Details WX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-139,122
Closed -$6.01M – 1051
2015
Q3 		$6.01M Buy
139,122
+3,600
+3% +$152K 0.23% 44
2015
Q2 		$5.73M Hold
135,522
– – 0.2% 64
2015
Q1 		$5.25M Buy
135,522
+37,551
+38% +$1.45M 0.16% 100
2014
Q4 		$3.3M Buy
97,971
+60,771
+163% +$2.15M 0.1% 215
2014
Q3 		$1.3M Hold
37,200
– – 0.04% 778
2014
Q2 		$1.22M Buy
37,200
+12,300
+49% +$421K 0.04% 806
2014
Q1 		$918K Sell
24,900
-19,900
-44% -$730K 0.03% 857
2013
Q4 		$1.72M Buy
44,800
+1,000
+2% +$31.6K 0.06% 410
2013
Q3 		$1.2M Buy
43,800
+10,900
+33% +$258K 0.05% 509
2013
Q2 		$691K Buy
+32,900
New +$642K 0.03% 732

Other funds holding WX

Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
CCS
Crosspoint Capital Strategies Orinda, California $50.4M AUM 15.37% 1-Year Est. Return

Liberty Mutual Group Asset Management's WX Position: Q4 2015 in Review

Liberty Mutual Group Asset Management sold out of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) in Q4 2015, closing a stake of 139,122 shares — an estimated $6.01M sold.

Liberty Mutual Group Asset Management first reported a position in WX in Q2 2013 and held it in 10 quarters. The position peaked at $6.01M in Q3 2015. 2 funds tracked by Wall St. Rank hold WX as of Q4 2015.

  • Liberty Mutual Group Asset Management reported no remaining WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position as of Q4 2015 after selling out during the quarter.
  • Liberty Mutual Group Asset Management sold 139,122 WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS shares in Q4 2015, an estimated $6.01M.
  • Liberty Mutual Group Asset Management first reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in Q2 2013 and held it in 10 quarters.
  • Liberty Mutual Group Asset Management's WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position peaked at $6.01M in Q3 2015.
  • 2 funds tracked by Wall St. Rank held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS as of Q4 2015.

Based on Liberty Mutual Group Asset Management's 13F filing for Q4 2015, filed 9 Feb 2016.